JP2018505022A5 - - Google Patents

Download PDF

Info

Publication number
JP2018505022A5
JP2018505022A5 JP2017558356A JP2017558356A JP2018505022A5 JP 2018505022 A5 JP2018505022 A5 JP 2018505022A5 JP 2017558356 A JP2017558356 A JP 2017558356A JP 2017558356 A JP2017558356 A JP 2017558356A JP 2018505022 A5 JP2018505022 A5 JP 2018505022A5
Authority
JP
Japan
Prior art keywords
corticosteroid
composition according
composition
injection site
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017558356A
Other languages
English (en)
Japanese (ja)
Other versions
JP7361451B2 (ja
JP2018505022A (ja
Filing date
Publication date
Priority claimed from US14/605,865 external-priority patent/US10441747B2/en
Application filed filed Critical
Priority claimed from PCT/US2016/014819 external-priority patent/WO2016123051A1/en
Publication of JP2018505022A publication Critical patent/JP2018505022A/ja
Priority to JP2023095451A priority Critical patent/JP2023113904A/ja
Publication of JP2018505022A5 publication Critical patent/JP2018505022A5/ja
Application granted granted Critical
Publication of JP7361451B2 publication Critical patent/JP7361451B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017558356A 2015-01-26 2016-01-26 脈管炎症を阻害するための方法およびシステム Active JP7361451B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023095451A JP2023113904A (ja) 2015-01-26 2023-06-09 脈管炎症を阻害するための方法およびシステム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/605,865 US10441747B2 (en) 2002-01-22 2015-01-26 Methods and systems for inhibiting vascular inflammation
US14/605,865 2015-01-26
PCT/US2016/014819 WO2016123051A1 (en) 2015-01-26 2016-01-26 Methods and systems for inhibiting vascular inflammation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023095451A Division JP2023113904A (ja) 2015-01-26 2023-06-09 脈管炎症を阻害するための方法およびシステム

Publications (3)

Publication Number Publication Date
JP2018505022A JP2018505022A (ja) 2018-02-22
JP2018505022A5 true JP2018505022A5 (https=) 2023-06-26
JP7361451B2 JP7361451B2 (ja) 2023-10-16

Family

ID=56544212

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017558356A Active JP7361451B2 (ja) 2015-01-26 2016-01-26 脈管炎症を阻害するための方法およびシステム
JP2023095451A Pending JP2023113904A (ja) 2015-01-26 2023-06-09 脈管炎症を阻害するための方法およびシステム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023095451A Pending JP2023113904A (ja) 2015-01-26 2023-06-09 脈管炎症を阻害するための方法およびシステム

Country Status (7)

Country Link
EP (1) EP3250277B1 (https=)
JP (2) JP7361451B2 (https=)
CN (1) CN107360713A (https=)
AU (1) AU2016211717B2 (https=)
BR (1) BR112017016048A2 (https=)
ES (1) ES2934140T3 (https=)
WO (1) WO2016123051A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018218182A1 (en) 2017-05-26 2018-11-29 Mercator Medsystems, Inc. Combination therapy for treatment of restenosis
CN116710103A (zh) * 2020-10-01 2023-09-05 墨卡托医疗系统公司 用于静脉血栓形成的血管周围抗炎疗法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69734060T2 (de) * 1996-05-24 2006-06-29 Angiotech Pharmaceuticals, Inc., Vancouver Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
AU2002249958B2 (en) * 2001-01-16 2007-11-08 Vascular Therapies, Inc. Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US20020188310A1 (en) 2001-06-08 2002-12-12 Seward Kirk Partick Microfabricated surgical device
US6547303B1 (en) 2001-08-13 2003-04-15 Johnson Controls Technology Company Pivoting seating system
US6860867B2 (en) 2001-09-20 2005-03-01 The Regents Of The University Of California Method of interventional surgery
US6547803B2 (en) 2001-09-20 2003-04-15 The Regents Of The University Of California Microfabricated surgical device for interventional procedures
AU2003205315A1 (en) 2002-01-22 2003-09-02 Endobionics, Inc. Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
US7744584B2 (en) * 2002-01-22 2010-06-29 Mercator Medsystems, Inc. Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation
US20050249776A1 (en) * 2003-12-19 2005-11-10 Chen Chao C Coated aneurysmal repair device
WO2005112569A2 (en) 2004-05-13 2005-12-01 Medtronic Vascular, Inc. Methods for compounding and delivering a therapeutic agent to the adventitia of a vessel
JP2005349202A (ja) * 2004-06-08 2005-12-22 Cordis Corp 治療薬を組織内へ導入する器具および方法
US20070269385A1 (en) * 2006-05-18 2007-11-22 Mercator Medsystems, Inc Devices, methods, and systems for delivering therapeutic agents for the treatment of sinusitis, rhinitis, and other disorders
US20100092534A1 (en) * 2008-10-10 2010-04-15 Medtronic Vascular, Inc. Combination Local Delivery Using a Stent
US20100233266A1 (en) * 2009-03-13 2010-09-16 Cleek Robert L Articles and methods of treating vascular conditions
US20120302954A1 (en) * 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
US9961079B1 (en) 2014-03-21 2018-05-01 Symantec Corporation Context aware intruder detection using WIFI MAC addresses

Similar Documents

Publication Publication Date Title
McKavanagh et al. Management and prevention of saphenous vein graft failure: a review
Oguzkurt et al. Impact of short-term hemodialysis catheters on the central veins: a catheter venographic study
Owens et al. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization
Lee Novel paradigms for dialysis vascular access: downstream vascular biology–is there a final common pathway?
Zhang et al. Low–Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation
Kassimis et al. High-speed rotational atherectomy using the radial artery approach and a sheathless guide: a single-centre comparison with the “conventional” femoral approach
Cui et al. Atorvastatin reduces in vivo fibrin deposition and macrophage accumulation, and improves primary patency duration and maturation of murine arteriovenous fistula
Zia et al. Safety and feasibility of transradial access for noncoronary and peripheral vascular interventions
JP2023113904A5 (https=)
JP2018505022A5 (https=)
Harper Drug‐eluting coronary stents—a note of caution
Atta et al. Colchicine inhibits intimal hyperplasia and leukocyte VEGF expression in dogs
Parikh et al. External beam radiation therapy to prevent postangioplasty dialysis access restenosis: a feasibility study
Takeda et al. A case report of very late stent thrombosis with peri-stent coronary artery aneurysm and stent-related coronary vasospasm
Wassélius et al. Treatment of mesenteric vein thrombosis with transjugular mechanical thrombectomy and subsequent simultaneous arterial and venous thrombolysis
Christenson et al. Treatment of infrapopliteal arterial occlusive disease in critical limb ischemia
Bienek et al. One single drug-coated balloon for all shapes/diameters? Neointimal proliferation inhibition in porcine peripheral arteries
CN106822900A (zh) Rna聚合酶i的抑制剂在抑制血管损伤后再狭窄的应用
JP3206321U (ja) マイクロカテーテル
Süselbeck et al. Direct versus conventional stent implantation in patients with acute coronary syndrome just before the era of drug-eluting stents
JP2018505022A (ja) 脈管炎症を阻害するための方法およびシステム
Won et al. Microcatheter placement through a side hole created in a 5-F catheter into proximal subclavian arterial branches causing hemoptysis
Garrioch et al. Reducing the risk of vascular surgery
Aoki et al. A case of spinal dural arteriovenous fistula presenting with unusually rapid progression of symptoms
Deiner et al. Nf-κb and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation